Skip to content

Lactobacillus paracasei weight loss effects: an on-site intervention trial

Lactobacillus paracasei weight loss effects: an on-site intervention trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112925
Enrollment
Unknown
Registered
2025-11-21
Start date
2025-11-22
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Control group:Oral administration does not produce Trp-CA by Lactobacillus paracasei
Test group:Oral administration of Lactobacillus paracasei producing Trp-CA

Sponsors

Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–60 years, male or female; 2. Body Mass Index (BMI) between 24.0–32.0 kg/m^2 (overweight or mildly obese); 3. Recent (past 3 months) weight fluctuation not exceeding +/-2 kg; 4. Able to comprehend study content, voluntarily sign informed consent, and agree to comply with study protocol requirements; 5. No history of major illnesses or severe metabolic disorders, able to attend follow-up appointments and provide samples as scheduled.

Exclusion criteria

Exclusion criteria: 1. Individuals with diabetes, severe cardiovascular disease, abnormal liver or kidney function, or thyroid dysfunction; 2. Those who have recently (within the past 3 months) used antibiotics, probiotic supplements, glucocorticoids, weight-loss medications, or drugs affecting metabolism; 3. Individuals with a history of gastrointestinal surgery, chronic diarrhea, or other conditions affecting nutrient absorption; 4. Individuals with allergies to dairy products or probiotic products, or those with severe lactose intolerance; 5. Pregnant women, breastfeeding women, or those planning pregnancy; 6. Individuals with a history of psychiatric disorders, substance abuse, or alcoholism that may affect compliance.

Design outcomes

Primary

MeasureTime frame
Weight;Waist circumference;Hip circumference;Fasting blood glucose;Systolic blood pressure;Diastolic blood pressure;Triglycerides;Total cholesterol;High-density lipoprotein cholesterol;Low-density lipoprotein cholesterol;Tryptophan-cholic acid;LC-19;

Countries

China

Contacts

Public ContactZhongze Fang

Tianjin Medical University

fangzhongze@tmu.edu.cn+86 183 2251 3076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026